Finally, it should be noted that ZnT5 polymorphisms have also been statistically associated with various pathological phenotypes in humans, including an increase in inflammatory markers, obesity, type 2 diabetes mellitus, colorectal cancer, and Alzheimer's disease.35 Here, SLC30A5 is linked to early-onset autosomal dominant Alzheimer disease.